142 related articles for article (PubMed ID: 15197103)
21. Aldosterone causes vasoconstriction in coronary arterioles of rats via angiotensin II type-1 receptor: influence of hypertension.
Kushibiki M; Yamada M; Oikawa K; Tomita H; Osanai T; Okumura K
Eur J Pharmacol; 2007 Oct; 572(2-3):182-8. PubMed ID: 17644087
[TBL] [Abstract][Full Text] [Related]
22. Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease.
van de Wal RM; van der Harst P; Wagenaar LJ; Wassmann S; Morshuis WJ; Nickenig G; Buikema H; Plokker HW; van Veldhuisen DJ; van Gilst WH; Voors AA
J Cardiovasc Pharmacol; 2007 Oct; 50(4):372-9. PubMed ID: 18049304
[TBL] [Abstract][Full Text] [Related]
23. Differential haemodynamic effects of endothelin receptor antagonist, SB 209670, in conscious hypertensive and normotensive rats.
Bunting MW; Widdop RE
Eur J Pharmacol; 1999 Sep; 381(1):13-21. PubMed ID: 10528129
[TBL] [Abstract][Full Text] [Related]
24. [Renal hemodynamic effect of angiotensin II type 2 receptor].
Hamada K
Nihon Jinzo Gakkai Shi; 2001; 43(1):28-34. PubMed ID: 11218315
[TBL] [Abstract][Full Text] [Related]
25. Angiotensin subtype 1 rReceptor (AT1) blockade improves vasorelaxation in heart failure by up-regulation of endothelial nitric-oxide synthase via activation of the AT2 receptor.
Thai H; Wollmuth J; Goldman S; Gaballa M
J Pharmacol Exp Ther; 2003 Dec; 307(3):1171-8. PubMed ID: 14560036
[TBL] [Abstract][Full Text] [Related]
26. Effects of candesartan and PD123319 on responses to angiotensin II in the anesthetized mouse.
Bivalacqua TJ; Dalal A; Lambert DG; Champion HC; Kadowitz PJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S98-100. PubMed ID: 9892148
[TBL] [Abstract][Full Text] [Related]
27. Tempol or candesartan prevents high-fat diet-induced hypertension and renal damage in spontaneously hypertensive rats.
Chung S; Park CW; Shin SJ; Lim JH; Chung HW; Youn DY; Kim HW; Kim BS; Lee JH; Kim GH; Chang YS
Nephrol Dial Transplant; 2010 Feb; 25(2):389-99. PubMed ID: 19749146
[TBL] [Abstract][Full Text] [Related]
28. Normalizing the expression of nitric oxide synthase by low-dose AT1 receptor antagonism parallels improved vascular morphology in hypertensive rats.
Bennai F; Morsing P; Paliege A; Ketteler M; Mayer B; Tapp R; Bachmann S
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S104-15. PubMed ID: 9892150
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin AT2 receptor stimulation causes neuroprotection in a conscious rat model of stroke.
McCarthy CA; Vinh A; Callaway JK; Widdop RE
Stroke; 2009 Apr; 40(4):1482-9. PubMed ID: 19246705
[TBL] [Abstract][Full Text] [Related]
30. Protective effect of candesartan in experimental ischemic stroke in the rat mediated by AT2 and AT4 receptors.
Faure S; Bureau A; Oudart N; Javellaud J; Fournier A; Achard JM
J Hypertens; 2008 Oct; 26(10):2008-15. PubMed ID: 18806625
[TBL] [Abstract][Full Text] [Related]
31. Pre-treatment with candesartan protects from cerebral ischaemia.
Ito T; Nishimura Y; Saavedra J
J Renin Angiotensin Aldosterone Syst; 2001 Sep; 2(3):174-9. PubMed ID: 11881119
[TBL] [Abstract][Full Text] [Related]
32. Angiotensin II blockade improves mitochondrial function in spontaneously hypertensive rats.
De Cavanagh EM; Toblli JE; Ferder L; Piotrkowski B; Stella I; Fraga CG; Inserra F
Cell Mol Biol (Noisy-le-grand); 2005 Nov; 51(6):573-8. PubMed ID: 16309582
[TBL] [Abstract][Full Text] [Related]
33. The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats.
Gardiner SM; Kemp PA; March JE; Woolley J; Bennett T
Br J Pharmacol; 1998 Dec; 125(7):1543-50. PubMed ID: 9884083
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effects of candesartan on responses to angiotensin peptides in the hindquarters vascular bed of the cat.
Lambert DG; Champion HC; Kadowitz PJ
Can J Physiol Pharmacol; 1998 Feb; 76(2):133-40. PubMed ID: 9635151
[TBL] [Abstract][Full Text] [Related]
35. Involvement of angiotensin II in cardiovascular and renal injury: effects of an AT1-receptor antagonist on gene expression and the cellular phenotype.
Kim S; Iwao H
J Hypertens Suppl; 1997 Dec; 15(6):S3-7. PubMed ID: 9493120
[TBL] [Abstract][Full Text] [Related]
36. Analysis of the effects of candesartan on responses to angiotensin II in the hindquarters vascular bed of the cat.
Champion HC; Bivalacqua TJ; Lambert DG; McNamara DB; Kadowitz PJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S101-3. PubMed ID: 9892149
[TBL] [Abstract][Full Text] [Related]
37. AT1 calcium signaling in renal vascular smooth muscle cells.
Iversen BM; Arendshorst WJ
J Am Soc Nephrol; 1999 Jan; 10 Suppl 11():S84-9. PubMed ID: 9892145
[TBL] [Abstract][Full Text] [Related]
38. Angiotensin-II subtype 2 receptor agonist (CGP-42112) inhibits catecholamine biosynthesis in cultured porcine adrenal medullary chromaffin cells.
Takekoshi K; Ishii K; Isobe K; Nanmoku T; Kawakami Y; Nakai T
Biochem Biophys Res Commun; 2000 Jun; 272(2):544-50. PubMed ID: 10833449
[TBL] [Abstract][Full Text] [Related]
39. Flow-dependent dilation mediated by endogenous kinins requires angiotensin AT2 receptors.
Bergaya S; Hilgers RH; Meneton P; Dong Y; Bloch-Faure M; Inagami T; Alhenc-Gelas F; Lévy BI; Boulanger CM
Circ Res; 2004 Jun; 94(12):1623-9. PubMed ID: 15131008
[TBL] [Abstract][Full Text] [Related]
40. Inhibition of NAD(P)H oxidase potentiates AT2 receptor agonist-induced natriuresis in Sprague-Dawley rats.
Sabuhi R; Asghar M; Hussain T
Am J Physiol Renal Physiol; 2010 Oct; 299(4):F815-20. PubMed ID: 20668101
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
